Filing Details
- Accession Number:
- 0000914062-13-000269
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-07 17:13:29
- Reporting Period:
- 2013-11-05
- Filing Date:
- 2013-11-07
- Accepted Time:
- 2013-11-07 17:13:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 939535 | G Steven Anderson | Cryolife, Inc. 1655 Roberts Boulevard, Nw Kennesaw GA 30144 | President, Ceo And Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-11-05 | 45,504 | $9.39 | 1,412,616 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-06 | 31,121 | $9.30 | 1,381,495 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-07 | 23,375 | $9.47 | 1,358,120 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 107,924 | Indirect | By Spouse |
Footnotes
- The sale reported in this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 21, 2013.
- Reflects weighted average price. Range of prices were between $9.3 and $9.55. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Reflects weighted average price. Range of prices were between $9.17 and $9.41. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Reflects weighted average price. Range of prices were between $9.29 and $9.76. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
